ESR2 and cancer: The risk of CRC also increased significantly in women after oophorectomy (45, 46), and 17β-estradiol treatment in vivo and in vitro inhibited CRC progression via ERβ-mediated actions (33–36), whilst promoted cancer progression through ERα (47–49).